A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is
Nihon Shoukaki Gan Kenshin Gakkai zasshi
Colorectal cancer (CRC) is amongst the most commonly encountered neoplasms worldwide, and both its prevalence and mortality have been increasing. Therefore, new strategies are needed to lower the burden of this disease. Recently, the effects of more than 200 agents (for example, nonsteroidal anti-inflammatory drugs (NSAIDs), aspirin and selective cyclooxygenase-2 (COX-2 ) inhibitors) in preventing or protecting against CRC development have been evaluated. However, there are as yet nodoi:10.11404/jsgcs.52.s159 fatcat:fjzhw5wconfm7n3okvwnllemmu